Bright light therapy can be effective treatment for seasonal affective disorder

An analysis published in Psychotherapy and Psychosomatics documents the value of light therapy in treating seasonal affective disorder. Seasonal affective disorder (SAD) is a subtype of recurrent major depressive or bipolar disorder defined by a regular temporal relationship (over at least 2 years) between the onset and remission of affective episodes and a particular time of the year. The most frequent pattern is fall-winter depression with onset of depression during fall or winter with spontaneous remission or, optionally, hypomania/mania during the subsequent spring/summer period. Bright light therapy has been used as a treatment for seasonal affective disorder for over 30 years.

This meta-analysis, including randomized, single- or double-blind clinical trials investigating Bright light therapy(≥1,000 lx, lightbox or light visor) against dim light (≤400 lx) or sham/low-density negative ion generators as placebo, assesses the efficacy of bright light therapy in the treatment of seasonal affective disorder in adults. Treatment effectiveness was evaluated as the post-treatment depression score measured by validated scales, and as the rate of response to treatment.

A total of 19 studies met inclusion criteria. Results showed that bright light therapy was superior over placebo with a standardized mean difference of -0.37 (95% CI: -0.63 to -0.12) for depression ratings (18 studies, 610 patients) and a risk ratio of 1.42 (95% CI: 1.08-1.85) for response to active treatment (16 studies, 559 patients).

Authors concluded that bright light therapy can be regarded as an effective treatment for seasonal affective disorder, but the available evidence stems from methodologically heterogeneous studies with small-to-medium sample sizes, necessitating larger high-quality clinical trials.

Source:
Journal reference:

Pjrek, E., et al. (2020) The Efficacy of Light Therapy in the Treatment of Seasonal Affective Disorder: A Meta-Analysis of Randomized Controlled Trials. Psychotherapy and Psychosomatics. doi.org/10.1159/000502891.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Psilocybin therapy reduces depression in clinicians after pandemic frontline work